Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 20, 2019 - Issue 18
Submit an article Journal homepage
851
Views
16
CrossRef citations to date
0
Altmetric
Review

Current pharmacotherapeutic options for myasthenia gravis

Carolina BarnettDepartment of Medicine (Neurology), University Health Network, University of Toronto – Neurology, Toronto, Ontario, CanadaView further author information
,
Raha TabasinejadDepartment of Medicine (Neurology), University Health Network, University of Toronto – Neurology, Toronto, Ontario, CanadaView further author information
&
Vera BrilDepartment of Medicine (Neurology), University Health Network, University of Toronto – Neurology, Toronto, Ontario, CanadaCorrespondence[email protected]
View further author information
Pages 2295-2303 | Received 19 Aug 2019, Accepted 16 Oct 2019, Published online: 31 Oct 2019

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Rui Chen, Ningyuan Zhang, Lili Gao, Ying Zhong, Ling Xu, Hongxia Liu, Qingshan Zheng & Lujin Li. (2021) Quantitative evaluation of drug efficacy in the treatment of myasthenia gravis. Expert Opinion on Investigational Drugs 30:12, pages 1231-1240.
Read now
Maria Alice V. Willrich, Karin M. P. Braun, Ann M. Moyer, David H. Jeffrey & Ashley Frazer-Abel. (2021) Complement testing in the clinical laboratory. Critical Reviews in Clinical Laboratory Sciences 58:7, pages 447-478.
Read now
Josefine Sell, Holger Haselmann, Stefan Hallermann, Michael Hust & Christian Geis. (2021) Autoimmune encephalitis: novel therapeutic targets at the preclinical level. Expert Opinion on Therapeutic Targets 25:1, pages 37-47.
Read now

Articles from other publishers (13)

Xin Chen, Jiayi Qiu, Zihui Gao, Boya Liu, Chen Zhang, Weiran Yu, Jiawen Yang, Yuntian Shen, Lei Qi, Xinlei Yao, Hualin Sun & Xiaoming Yang. (2023) Myasthenia gravis: Molecular mechanisms and promising therapeutic strategies. Biochemical Pharmacology 218, pages 115872.
Crossref
Rodrigo Martinez-Harms, Carolina Barnett & Vera Bril. (2023) Time to achieve a patient acceptable symptom state in myasthenia gravis. Frontiers in Neurology 14.
Crossref
Tanya R Riley, Janine S Douglas, Christopher Wang & Kiarra M Bowser. (2023) An update of the pharmacological treatment options for generalized myasthenia gravis in adults with anti–acetylcholine receptor antibodies. American Journal of Health-System Pharmacy 80:11, pages 652-662.
Crossref
Konstantinos Lazaridis, Maria Fernandez-Santoscoy, Vasiliki Baltatzidou, Jan-Olof Andersson, Richard Christison, John Grünberg, Socrates Tzartos, Björn Löwenadler & Charlotte Fribert. (2022) A Recombinant Acetylcholine Receptor α1 Subunit Extracellular Domain Is a Promising New Drug Candidate for Treatment Of Myasthenia Gravis. Frontiers in Immunology 13.
Crossref
Jan JGM Verschuuren, Jacqueline Palace, Hiroyuki Murai, Martijn R Tannemaat, Henry J Kaminski & Vera Bril. (2022) Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders. The Lancet Neurology 21:2, pages 189-202.
Crossref
Onur Akan, Emre Can Polat, Mehmet Gökhan Çulha & Suzan Deniz Önol. (2021) The impact of myasthenia gravis on lower urinary tract functions. International Journal of Clinical Practice 75:12.
Crossref
Weiwei Duan, Yuyao Peng, Wanlin Jin, Song Ouyang & Huan Yang. (2021) Tacrolimus as Single-Agent Immunotherapy and Minimal Manifestation Status in Nonthymoma Myasthenia Gravis. Journal of Immunology Research 2021, pages 1-7.
Crossref
Syed Mohammed Basheeruddin Asdaq, Syed Imam Rabbani, Meshary Alkahtani, Meshal Meshary Aldohyan, Abdullah Mohammad Alabdulsalam, Majed Sadun Alshammari, Saleh Ahmad Alajlan, Aljawharah Binrokan, Yahya Mohzari, Ahmed Alrashed, Mohammed Kanan Alshammari, Mohd. Imran & Naira Nayeem. (2021) A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19. International Journal of Molecular Sciences 22:21, pages 11953.
Crossref
Christopher Tran, Aishani Biswas, Meg Mendoza, Hans Katzberg, Vera Bril & Carolina Barnett. (2020) Performance of different criteria for refractory myasthenia gravis. European Journal of Neurology 28:4, pages 1375-1384.
Crossref
Marina Noris, Ariela Benigni & Giuseppe Remuzzi. (2020) The case of complement activation in COVID-19 multiorgan impact. Kidney International 98:2, pages 314-322.
Crossref
Elena Cortés-Vicente, Eduard Gallardo, Rodrigo Álvarez-Velasco & Isabel Illa. (2020) Myasthenia Gravis Treatment Updates. Current Treatment Options in Neurology 22:8.
Crossref
Lin Wang & Lijuan Zhang. (2020) Emerging Roles of Dysregulated MicroRNAs in Myasthenia Gravis. Frontiers in Neuroscience 14.
Crossref
Konstantinos Lazaridis & Socrates J. Tzartos. (2020) Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics. Frontiers in Immunology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.